Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumors × veliparib × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Glioma 1 Ependymoma 1

Interventions

Gemcitabine 5 Paclitaxel 3 Nivolumab 3 cobimetinib 2 atezolizumab 2 Ramucirumab 2 Carboplatin 2 zansecimab 1 tocilizumab 1 tivozanib 1 tislelizumab 1 temsirolimus 1 ridaforolimus 1 plocabulin 1 pevonedistat 1 pembrolizumab 1 pamiparib 1 obinutuzumab 1 necitumumab 1 liposomal doxorubicin 1 lenvatinib 1 glasdegib 1 futuximab 1 demplatin pegraglumer 1 birinapant 1 adavosertib 1 Temozolomide 1 TAK-981 1 Sunitinib 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡